The medtech startup founded by physician and Farapulse inventor Steven Mickelsen is preparing to begin a pivotal study of ...

BioStar Capital and Cue Growth co-lead financing to accelerate pivotal trial readiness and expand the ventricular tachycardia ...

Stereotaxis (NYSE:STXS) announced the publication of initial clinical results using its MAGiC robotic magnetic navigation ...

"Supported by MAARS, clinicians can deliver personalized care to their patients and protect them appropriately from SCDA ...

Field Medical has generated another $35 million in venture capital funding for its cardiac pulsed field ablation system to support the launch of a pivotal trial. | The series B financing comes quickly ...

New AI techniques to add to VT ablation toolsFORT MILL, S.C., June 30, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing ...

Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, ...

The AI analysis resulted in 14 times fewer missed diagnoses of conditions like complete heart block, ventricular tachycardia, ...

Field Medical announced today that it has closed a Series B funding round worth proceeds totaling $35 million.

Modern medicine particularly the use of pacemakers and implantable cardioverter defibrillators (ICDs) is changing how we approach prevention of potentially life-threatening events ...